TIME-DEPENDENT ANALYSIS OF SELECTIVE SEROTONIN REUPTAKE INHIBITOR TREATMENT ON OVERALL SURVIVAL OF PATIENTS WITH GLIOBLASTOMA

被引：0
|
作者：
Otto-Meyer, Sebastian [1 ]
DeFaccio, Rian [1 ]
Dussold, Corey [1 ]
Ladomersky, Erik [2 ]
Lukas, Rimas [3 ]
Amidei, Christina [1 ]
Zhai, Lijie [2 ]
Lauing, Kristen [2 ]
Scholtens, Denise [1 ]
Wainwright, Derek [2 ]
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Neurol Surg, Chicago, IL 60611 USA
[3] Northwestern Med, Chicago, IL USA
来源：
NEURO-ONCOLOGY | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
HOUT-20
引用
收藏
页码：116 / 116
页数：1
相关论文
共 50 条
  • [1] SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) TREATMENT IS ASSOCIATED WITH IMPROVED SURVIVAL AMONG ELDERLY PATIENTS DIAGNOSED WITH GLIOBLASTOMA
    Otto-Meyer, Sebastian
    Ladomersky, Erik
    Scholtens, Denise
    Zhai, Lijie
    Lauing, Kristen
    Amidei, Christina
    Lukas, Rimas
    Wainwright, Derek
    NEURO-ONCOLOGY, 2018, 20 : 115 - 115
  • [2] A retrospective survival analysis of Glioblastoma patients treated with selective serotonin reuptake inhibitors
    Otto-Meyer, Sebastian
    Defaccio, Rian
    Dussold, Corey
    Ladomersky, Erik
    Zhai, Lijie
    Lauing, Kristen L.
    Bollu, Lakshmi R.
    Amidei, Christina
    Lukas, Rimas, V
    Scholtens, Denise M.
    Wainwright, Derek A.
    BRAIN, BEHAVIOR, & IMMUNITY - HEALTH, 2020, 2
  • [3] The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis
    Goldman, Debra A.
    Hovinga, Koos
    Reiner, Anne S.
    Esquenazi, Yoshua
    Tabar, Viviane
    Panageas, Katherine S.
    JOURNAL OF NEUROSURGERY, 2018, 129 (05) : 1231 - 1239
  • [4] Time-dependent inhibition of CYP3A4 by sertraline, a selective serotonin reuptake inhibitor
    Masubuchi, Yasuhiro
    Kawaguchi, Yuki
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2013, 34 (08) : 423 - 430
  • [5] Selective Serotonin Reuptake Inhibitors, Glioblastoma Multiforme, and Impact on Toxicities and Overall Survival The Mayo Clinic Experience
    Caudill, Jonathan S.
    Brown, Paul D.
    Cerhan, Jane H.
    Rummans, Teresa A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (04): : 385 - 387
  • [6] Safety of selective serotonin reuptake inhibitor treatment in recovering stroke patients
    Mortensen, Janne Kaergaard
    Andersen, Grethe
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (06) : 911 - 919
  • [7] Time-dependent association between selective serotonin reuptake inhibitors and hospitalization due to hyponatremia
    Mannheimer, Buster
    Falhammar, Henrik
    Calissendorff, Jan
    Skov, Jakob
    Lindh, Jonatan D.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2021, 35 (08) : 928 - 933
  • [8] Treatment of verbal agitation with a selective serotonin reuptake inhibitor
    Ramadan, FH
    Naughton, BJ
    Bassanelli, AG
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2000, 13 (02) : 56 - 59
  • [9] Effects of Selective Serotonin Reuptake Inhibitor Treatment on Ovarian Reserves in Patients with Depression
    Gok, Soner
    Gok, Berfin Can
    Alatas, Erkan
    Senol, Hande
    Topak, Osman Zuelkif
    MEDICINA-LITHUANIA, 2023, 59 (03):
  • [10] Age-Dependent Sex Differences in the Prevalence of Selective Serotonin Reuptake Inhibitor Treatment: A Retrospective Cohort Analysis
    Sanchez-Ruiz, Jorge A.
    Leibman, Nicole I.
    Larson, Nicholas B.
    Jenkins, Gregory D.
    Ahmed, Ahmed T.
    Nunez, Nicolas A.
    Biernacka, Joanna M.
    Winham, Stacey J.
    Weinshilboum, Richard M.
    Wang, Liewei
    Frye, Mark A.
    Ozerdem, Aysegul
    JOURNAL OF WOMENS HEALTH, 2023, 32 (11) : 1229 - 1240
12345